ReviewNaunyn-Schmiedeberg's archives of pharmacology2025
Transformative potential of plant-based nanoparticles in cancer diagnosis and treatment: bridging traditional medicine and modern therapy.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin.Materials today. Bio · 2025Review
- Emerging Role of Plant-Derived Nanostructures in Nanomedicine.International journal of nanomedicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a primary global health concern, with an estimated 35.3 million cancer cases expected worldwide, representing a 76.6% increase in 2022, and 20 million by 2050, resulting from genetic mutation and environmental factors that cause uncontrolled cell growth. Other factors including smoking, unhealthy diets, physical inactivity, exposure to carcinogens, UV radiation, and aging increase DNA damage. Current cancer treatments like chemotherapy, radiation therapy, immunotherapy, and surgery are effective, but those have significant effects like lack of specificity, development of drug resistance, and significant side effects to healthy tissues. An advancement to conventional therapies is plant-based nanoparticles as transformative approaches in cancer diagnosis and treatment. These nanoparticles synthesized using plant bioactive compounds like flavonoids, alkaloids, polyphenols, and some metals-oxides like gold, silver, copper, zinc, etc. offer eco-friendly, cost-effective, and biocompatible alternatives. They enhance targeted drug delivery, allowing anticancer agents specifically to tumor cells, minimizing damage to health. Improves imaging techniques like MRI and fluorescence imaging, and helps early detection, cancer biomarkers, allowing for prompt intervention. Recent findings show that nanocarriers made from plant-based materials, such as polyphenols (curcumin, resveratrol) and plant-extracted metal nanoparticles (gold, silver), can improve drug stability and selectively target tumor cells. Plant-derived nanoparticles play a crucial role in cancer immunotherapy and nanovaccines. Biodegradable plant-based nanocarriers can deliver cancer vaccines, stimulating long-term immunity against tumors. Graphene oxide and gold nanoparticles synthesized from plant extracts can absorb near-infrared (NIR) light, generating heat to destroy cancer cells with minimal damage to surrounding tissues. This study discusses the types of plant-based nanoparticles like plant virus nanoparticles (TMV, PVX, CPMV), plant metallic nanoparticles (Au, Ag., Cu, Zn, Mg, Ca, and Mn), and flavonoid nanoparticles found in cancer treatment, their significant roles, chemotherapy-based nanomedicines available in the medical field, and a detailed vision of nanomaterial applications in cancer diagnosis, treatment, and targeted drug delivery.
Indexed as
Identifiers
40237799What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.